These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 27388687)

  • 1. Quality of life in patients with adrenal insufficiency correlates stronger with hydrocortisone dosage, than with long-term systemic cortisol levels.
    Andela CD; Staufenbiel SM; Joustra SD; Pereira AM; van Rossum EF; Biermasz NR
    Psychoneuroendocrinology; 2016 Oct; 72():80-6. PubMed ID: 27388687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated hair cortisol concentrations in children with adrenal insufficiency on hydrocortisone replacement therapy.
    Noppe G; van Rossum EF; Vliegenthart J; Koper JW; van den Akker EL
    Clin Endocrinol (Oxf); 2014 Dec; 81(6):820-5. PubMed ID: 25039686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased Hair Cortisol Concentrations and BMI in Patients With Pituitary-Adrenal Disease on Hydrocortisone Replacement.
    Staufenbiel SM; Andela CD; Manenschijn L; Pereira AM; van Rossum EF; Biermasz NR
    J Clin Endocrinol Metab; 2015 Jun; 100(6):2456-62. PubMed ID: 25816049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hair cortisol content in patients with adrenal insufficiency on hydrocortisone replacement therapy.
    Gow R; Koren G; Rieder M; Van Uum S
    Clin Endocrinol (Oxf); 2011 Jun; 74(6):687-93. PubMed ID: 21521272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of hydrocortisone dosage scheme on health-related quality of life in patients with adrenal insufficiency.
    Bleicken B; Hahner S; Loeffler M; Ventz M; Decker O; Allolio B; Quinkler M
    Clin Endocrinol (Oxf); 2010 Mar; 72(3):297-304. PubMed ID: 19508599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decrease in salivary cortisol levels after glucocorticoid dose reduction in patients with adrenal insufficiency: A prospective proof-of-concept study.
    Ceccato F; Barbot M; Lizzul L; Selmin E; Saller A; Albiger N; Betterle C; Boscaro M; Scaroni C
    Clin Endocrinol (Oxf); 2018 Feb; 88(2):201-208. PubMed ID: 28973827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Usefulness of Time-Point Serum Cortisol and ACTH Measurements for the Adjustment of Glucocorticoid Replacement in Adrenal Insufficiency.
    Rousseau E; Joubert M; Trzepla G; Parienti JJ; Freret T; Vanthygem MC; Desailloud R; Lefebvre H; Coquerel A; Reznik Y;
    PLoS One; 2015; 10(8):e0135975. PubMed ID: 26317782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low Impact of Urinary Cortisol in the Assessment of Hydrocortisone Replacement Therapy.
    Haas CS; Rahvar AH; Danneberg S; Lehnert H; Moenig H; Harbeck B
    Horm Metab Res; 2016 Sep; 48(9):571-4. PubMed ID: 27300473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring the Impact of Short- and Long-Term Hydrocortisone Replacement on Cognitive Function, Quality of Life and Catecholamine Secretion: A Pilot Study.
    Harbeck B; Danneberg S; Rahvar AH; Haas CS; Lehnert H; Kropp P; Mönig H
    Appl Psychophysiol Biofeedback; 2016 Sep; 41(3):341-7. PubMed ID: 27170300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patients with adrenal insufficiency hate their medication: concerns and stronger beliefs about the necessity of hydrocortisone intake are associated with more negative illness perceptions.
    Tiemensma J; Andela CD; Pereira AM; Romijn JA; Biermasz NR; Kaptein AA
    J Clin Endocrinol Metab; 2014 Oct; 99(10):3668-76. PubMed ID: 25226291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychological morbidity and impaired quality of life in patients with stable treatment for primary adrenal insufficiency: cross-sectional study and review of the literature.
    Tiemensma J; Andela CD; Kaptein AA; Romijn JA; van der Mast RC; Biermasz NR; Pereira AM
    Eur J Endocrinol; 2014 Aug; 171(2):171-82. PubMed ID: 24801589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiometabolic and psychological effects of dual-release hydrocortisone: a cross-over study.
    Dineen R; Martin-Grace J; Ahmed KMS; Frizelle I; Gunness A; Garrahy A; Hannon AM; O'Reilly MW; Smith D; McDermott J; Healy ML; Agha A; Pazderska A; Gibney J; Thompson CJ; Behan LA; Sherlock M
    Eur J Endocrinol; 2021 Feb; 184(2):253-265. PubMed ID: 33513125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved cortisol exposure-time profile and outcome in patients with adrenal insufficiency: a prospective randomized trial of a novel hydrocortisone dual-release formulation.
    Johannsson G; Nilsson AG; Bergthorsdottir R; Burman P; Dahlqvist P; Ekman B; Engström BE; Olsson T; Ragnarsson O; Ryberg M; Wahlberg J; Biller BM; Monson JP; Stewart PM; Lennernäs H; Skrtic S
    J Clin Endocrinol Metab; 2012 Feb; 97(2):473-81. PubMed ID: 22112807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of short-term nocturnal cortisol replacement on cognitive function and quality of life in patients with primary or secondary adrenal insufficiency: a pilot study.
    Harbeck B; Kropp P; Mönig H
    Appl Psychophysiol Biofeedback; 2009 Jun; 34(2):113-9. PubMed ID: 19387826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perioperative Glucocorticoid Therapy for Patients with Adrenal Insufficiency: Dosing Based on Pharmacokinetic Data.
    Arafah BM
    J Clin Endocrinol Metab; 2020 Mar; 105(3):. PubMed ID: 31996925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GLUCOCORTICOID REPLACEMENT REGIMENS IN CHRONIC ADRENAL INSUFFICIENCY: A SYSTEMATIC REVIEW AND META-ANALYSIS.
    Al Nofal A; Bancos I; Benkhadra K; Ospina NM; Javed A; Kapoor E; Muthusamy K; Brito JP; Turcu AF; Wang Z; Prokop L; Erickson DZ; Lteif AN; Natt N; Murad MH
    Endocr Pract; 2017 Jan; 23(1):17-31. PubMed ID: 27631672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Replacement therapy of oral hydrocortisone in adrenal insufficiency: the influence of gastrointestinal factors.
    Lennernäs H; Skrtic S; Johannsson G
    Expert Opin Drug Metab Toxicol; 2008 Jun; 4(6):749-58. PubMed ID: 18611115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of glucocorticoid therapy with salivary cortisol in secondary adrenal insufficiency.
    Ceccato F; Albiger N; Reimondo G; Frigo AC; Ferasin S; Occhi G; Mantero F; Terzolo M; Scaroni C
    Eur J Endocrinol; 2012 Dec; 167(6):769-76. PubMed ID: 23034783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Poor quality of life and sleep in patients with adrenal insufficiency-another cause of increased mortality?
    Blacha AK; Kropp P; Rahvar AH; Flitsch J; van de Loo I; Harbeck B
    Ir J Med Sci; 2022 Aug; 191(4):1653-1658. PubMed ID: 34389925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pediatric Cancer Survivorship: Impact Upon Hair Cortisol Concentration and Family Functioning.
    Erickson SJ; Dinces S; Kubinec N; Annett RD
    J Clin Psychol Med Settings; 2022 Dec; 29(4):943-953. PubMed ID: 35150359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.